Drug: LAMIVUDINE. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 70 Number of Pages: 4
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 73265815 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160909 | US | |
| 73285784 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160705 | US | |
| 94991263 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | 2 KG | 20160720 | US | |
| 94991303 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | 1 KG | 20160720 | US | |
| 97053473 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160719 | IT | |
| 97053484 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160720 | IT | |
| 97053493 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160720 | IT | |
| 97053503 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160719 | IT | |
| 97053513 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160719 | IT | |
| 97053523 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160720 | IT | |
| 97053533 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160720 | IT | |
| 97053543 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | 0 | 20160712 | US | |
| 97053593 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160720 | IT | |
| 97053604 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160824 | IT | |
| 97054503 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160720 | IT | |
| 97566543 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160722 | ET | |
| 117311873 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | 3 KG | 20160826 | DE | |
| 118687852 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | F | 3 KG | 20160901 | US |
| 119535702 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 15.00 MON | M | 3 KG | 20160721 | PT |
| 125224641 | LAMIVUDINE. | Foetal exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | M | 3 KG | 20160701 | COUNTRY NOT SPECIFIED |
Total Records: 70 Number of Pages: 4